Jazz Pharmaceuticals Aktie

Kaufen
Verkaufen
116,85 EUR -1,15 EUR -0,97 %
122,97 USD +0,14 USD +0,11 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 7,12 Mrd. EUR

KGV 20,16 Div. Rendite 0,00%

WKN A1JS1K

ISIN IE00B4Q5ZN47

Symbol JAZZ


Jazz Pharmaceuticals Aktie Analyse

11.06.19 Jazz Pharmaceuticals overweight Barclays Capital
08.11.18 Jazz Pharmaceuticals Buy B. Riley FBR
08.08.18 Jazz Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
08.11.17 Jazz Pharmaceuticals Outperform RBC Capital Markets
19.10.17 Jazz Pharmaceuticals Buy FBR & Co.
15.05.17 Jazz Pharmaceuticals Outperform RBC Capital Markets
21.03.17 Jazz Pharmaceuticals Buy Mizuho
21.02.17 Jazz Pharmaceuticals Buy Mizuho
09.11.16 Jazz Pharmaceuticals Buy Mizuho
19.07.16 Jazz Pharmaceuticals Buy Mizuho
11.05.16 Jazz Pharmaceuticals Buy UBS AG
11.05.16 Jazz Pharmaceuticals Buy Mizuho
25.04.16 Jazz Pharmaceuticals Buy SunTrust Robinson Humphrey, Inc.
14.10.15 Jazz Pharmaceuticals Outperform Northland Capital
09.10.15 Jazz Pharmaceuticals Buy Mizuho
29.06.15 Jazz Pharmaceuticals Buy UBS AG
25.02.15 Jazz Pharmaceuticals Buy Deutsche Bank AG
20.02.15 Jazz Pharmaceuticals Outperform BMO Capital Markets
05.11.14 Jazz Pharmaceuticals Buy R. F. Lafferty
29.11.12 Jazz Pharmaceuticals buy UBS AG
22.06.12 Jazz Pharmaceuticals overweight Barclays Capital
23.05.12 Jazz Pharmaceuticals outperform Oppenheimer & Co. Inc.